Walgreen Company March Results Outpace Rite Aid Corporation's

Both Walgreen and Rite Aid reported March sales today; once again Walgreen saw much higher growth than Rite Aid.

Apr 3, 2014 at 11:57AM

Today Rite Aid (NYSE:RAD) and Walgreen (NASDAQ:WBA) each reported sales for March, and the two drugstore chains had dramatically different results.

Walgreen announced that its comparable sales -- a metric measuring sales at stores that have been open for more than a year -- rose by 3.5%, and Rite Aid noted its same-store sales increased by less than one quarter of that amount at just 0.7%.

Each firm disclosed that its front-end sales decreased as a result of the timing of the Easter holiday -- on April 20 of this year versus March 31 of last year: Walgreen front-end sales fell 3.4% and Rite Aid's fell 5%. Rite Aid said the timing of the holiday was responsible for a 4.1% reduction in sales, whereas Walgreen did not disclose a specific amount in its press release.

In addition the firms both reported that pharmacy same-store sales rose, but once again the difference between the two was dramatic. Rite Aid saw its pharmacy sales rise by 3.5%, but suggested this was negatively affected by 1.3 percentage points as a result of the introduction of generic drugs. Walgreen noted its same-store pharmacy sales overall increased by 8%, but said it saw a drop of 1.6 percentage points from generic drugs.

Walgreen also noted it saw a positive impact of 0.9 percentage points from the timing of the calendar days, as March this year had one additional Monday and one less Friday versus 2013. Rite Aid did not disclose whether or not its pharmacy sales were positively or negatively affected by the shifting days.

Rite Aid saw its same-store total prescription count increase by 1.1% and Walgreen saw its prescriptions rise by 5.1%. In total, prescriptions accounted for 69.4% of sales at Rite Aid and 64.7% of sales at Walgreen.

Rite Aid was also outpaced by Walgreen in February, as its same-store -sales rose by 1.5%, whereas the comparable store sales at Walgreen rose by 4.5%.

Walgreen and Rite Aid are the nation's largest and third-largest drugstore chains, respectively, based on the number of stores. Walgreen had 8,221 drugstores at the end of last month, while Rite Aid operated 4,584. The second-largest, CVS Caremark Corp., which has more than 7,600 CVS/pharmacy stores, doesn't report monthly sales publicly. 

-- Material from The Associated Press was used in this report.

link

Patrick Morris has no position in any stocks mentioned. The Motley Fool recommends CVS Caremark. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers